http://rdf.ncbi.nlm.nih.gov/pubchem/reference/12126988

Outgoing Links

Predicate Object
contentType Journal Article|Multicenter Study|Randomized Controlled Trial|Research Support, Non-U.S. Gov't
endingPage 831
issn 0040-6376
1468-3296
issueIdentifier 9
pageRange 825-831
publicationName Thorax
startingPage 825
bibliographicCitation Paci E, Puliti D, Lopes Pegna A, Carrozzi L, Picozzi G, Falaschi F, Pistelli F, Aquilini F, Ocello C, Zappa M, Carozzi FM, Mascalchi M; the ITALUNG Working Group. Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial. Thorax. 2017 Sep;72(9):825–31. doi: 10.1136/thoraxjnl-2016-209825. PMID: 28377492.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c0b76357756c69ee9d883846342e5bdf
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6288f88199df035bc4cbe8994e58a096
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f3d1478e76d61561ae3408b98956d6a1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d49deef9d61cbaf7426a988612eb74e4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_283f2c5541929c07693cb79b468f4bca
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_05cc1f1039809eac526cedb1ad2d357f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cddb8b3a74633c9594b5c8d0523a60ea
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_18ef4ce459b47df5178eacc8b0417da9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5541ef240eacb9f13e0a41cb64c197fb
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_66a0b04c155c5da506613c0653ad86ad
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_abe8f4e981b10478e4f6bd165e160616
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b7a60bdfbb28c81a17783b245b24084e
date 2017-04-04^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1136/thoraxjnl-2016-209825
https://pubmed.ncbi.nlm.nih.gov/28377492
isPartOf https://portal.issn.org/resource/ISSN/1468-3296
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/7730
https://portal.issn.org/resource/ISSN/0040-6376
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D008175Q000000981
http://id.nlm.nih.gov/mesh/D055088Q000379
hasSubjectTerm http://id.nlm.nih.gov/mesh/D053208
http://id.nlm.nih.gov/mesh/D012042
http://id.nlm.nih.gov/mesh/D008175Q000601
http://id.nlm.nih.gov/mesh/D008175Q000209
http://id.nlm.nih.gov/mesh/D008175Q000473
http://id.nlm.nih.gov/mesh/D009367
http://id.nlm.nih.gov/mesh/D007558Q000453
http://id.nlm.nih.gov/mesh/D005500
http://id.nlm.nih.gov/mesh/D012907Q000453
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D000368
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D008175Q000453
http://id.nlm.nih.gov/mesh/D012907Q000009
http://id.nlm.nih.gov/mesh/D014057Q000379
http://id.nlm.nih.gov/mesh/D015994
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8366

Showing number of triples: 1 to 53 of 53.